Nazartinib ;EGF816; NVS-816- Shanghai Caerulum Pharma Discovery

Home>Product>Nazartinib ;EGF816; NVS-816

Nazartinib ;EGF816; NVS-816

Purchase Qty: 5
Unit: g(s)
Fob Unit Price: US $3800
Payment Terms:T/T , PayPal

Favorite

Shanghai Caerulum Pharma Discovery

Business Type:Manufacturer

Country/Region:China

Ddu Verified

HOT Rank

8/10

Product Information

CAS:1508250-71-2
Active Ingredients:(R,E)-N-(7-chloro-1-(1-(4-(dimethylamino)but-2-enoyl)azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide
Chemical Formula:C26H31ClN6O2
Molecular Weight:495.02
Assay:min 98%
Pharmacopeia:CP
Shelf Life:2 years
Storage:Sealed
Place of Origin:China

Description

Nazartinib, also known as EGF816 and NVS-816, is an orally available, irreversible, third-generation, mutant-selective epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity. EGF816 covalently binds to and inhibits the activity of mutant forms of EGFR, including the T790M EGFR mutant, thereby preventing EGFR-mediated signaling.

Shanghai Caerulum Pharma Discovery is the manufacturer of APIs and intermediates of some of the latest compounds in the market. Our focus is on cancer, diabetes and other therapeutic areas.

Shanghai Caerulum Pharma Discovery (CPD) offers high quality and reliable chemical products and integrated biological services including:

1) Best offer for existing APIs and intermediates

2) Custom-synthesis APIs and intermediates

3) DMPK

4) Biological screening

5) Drug Safety Evaluation